Significant Contract Modifications ($10M+) — December 23, 2025

Four DOE contracts totaling $57B (64% of period value) for site/lab operations through 2026-2027 ensure multi-decade revenue stability under cost-plus structures with $18.7B already outlayed.

Eight NASA awards worth $6.6B highlight entrenched positions in ISS/crew/facilities support, with $4.8B outlayed and extensions to 2030, underscoring Boeing/SpaceX/Jacobs leadership.

Nine GSA delivery orders totaling $2.6B (up to $7B with options) for engineering/IT services through 2029 signal backlog growth for Booz Allen, CACI, Peraton amid non-competitive scaling.

Four HHS contracts ($1.2B obligated, $8.3B options ceiling) for MAC hosting/vaccines through 2029 provide recurring revenue, with 70%+ outlayed in key awards.

Two neutral DOE lab management contracts ($31B total) for Argonne/SLAC through 2026-2027 offer cost-no-fee stability but no equity upside as educational nonprofits.

Low/no outlays in 12 contracts ($5.5B total obligation) despite large awards signal potential funding delays or pacing issues.

13 contracts end 2025-2026 ($15B+ value) with recompetition risk post-period.

Firm fixed price in 8 contracts ($2B+) exposes to cost overruns amid inflation/labor pressures.

High subawards (avg. 25% of value, up to $673M in one) in 25 contracts introduce subcontractor dependencies.

$20B+ unexercised options across 25 contracts, e.g., McKesson ($8.1B ceiling vs $153M obligated), offer 2-50x upside if exercised.

Extensions to 2028-2030 in 15 contracts (e.g., SpaceX Commercial Crew to 2030) align with sustained space/nuclear priorities.

Small/SDVOSB set-asides (5 contracts, $1B+) position niche players for follow-ons.

GSA IDIQ task orders (9 awards) enable rapid scaling to ceilings >3x obligated value.

DOE's $57B in ops/mgmt mods (62% period value) reflect priority on Savannah River/Hanford/ANL/SLAC amid energy security push.

NASA's $6.6B across ISS/crew/facilities underscores 30+ year commitments to incumbents.

$2.6B obligated (to $7B+ potential) signals defense/cyber modernization via cost-plus awards.

Health IT/vaccine/distribution contracts ($1.2B to $9B ceiling) highlight post-pandemic infrastructure needs.

{"entity"=>"Fluor Corp (Savannah River $25B)", "reason"=>"Largest single award (27% period value); $11.7B options through 2026", "trigger"=>"option exercises or recompete notice"}

{"entity"=>"Boeing ($22B NASA ISS)", "reason"=>"33-year lifeline with $20B remaining obligation", "trigger"=>"outlay acceleration >$500M/qtr"}

{"entity"=>"McKesson ($8.1B vaccine options)", "reason"=>"Explosive 50x ceiling vs. $153M base; CDC recurring need", "trigger"=>"initial option exercise >$1B"}

{"entity"=>"SpaceX ($3B Commercial Crew)", "reason"=>"$110M options + post-certification missions to 2030", "trigger"=>"NASA mission task orders"}

{"entity"=>"Booz Allen ($2.6B GSA SSMARTT)", "reason"=>"Recent award with $2.2B options; $0 outlayed flags ramp", "trigger"=>"FY2026 outlays >$100M"}

{"entity"=>"Contracts with $0 outlay ($5.5B)", "reason"=>"10 awards (e.g., BL Harbert embassy) risk delays", "trigger"=>"outlay starts or de-obligation"}